MasterControl News Archive

May 23, 2019 by Dave Edwards

In the wake of the Theranos disaster, Dave Edwards, executive vice president of sales at MasterControl, explains why digital transformation is key if pharma companies are to achieve transparency throughout product development.

 

How to avoid pharma's Theranos effect

Contact: Jennifer Hurst, Sr. Director, PR & Content
Phone: 1.801.560.9608
Email: [email protected]

Not long ago, everyone was clamouring over Theranos founder Elizabeth Holmes drafted a captivating pitch, courted investors and even partnered with Walgreens to open blood testing centres in California and Arizona. Theranos seemed too good to be true, and it was.

olmes and former-Theranos president Ramesh Balwani misled the public through a systematic lack of transparency. The company did not have peer-reviewed evidence showing the safety and effectiveness of its machine, and soon holes were poked in Holmes’ narrative, leading to the company’s ultimate demise.

Read the full article here.

About MasterControl
MasterControl Inc. is a leading provider of cloud-based quality and compliance software for life sciences and other regulated industries. Our mission is the same as that of our customers – to bring life-changing products to more people sooner. The MasterControl Platform helps organizations digitize, automate and connect quality and compliance processes across the regulated product development life cycle. Over 1,000 companies worldwide rely on MasterControl solutions to achieve new levels of operational excellence across product development, clinical trials, regulatory affairs, quality management, supply chain, manufacturing and postmarket surveillance. For more information, visit www.mastercontrol.com.